Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 11, 2026
Current state of medical care for patients with mycosis fungoides and Sézary syndrome at a German university hospital - a cross-sectional studyInga Hansen-Abeck, Larissa Kölln, Finn Abeck, et al.
NPJ Precision Oncology|March 24, 2022
Emerging precision diagnostics in advanced cutaneous squamous cell carcinomaGlenn Geidel, Isabel Heidrich, Julian Kött, et al.
Cancers|September 13, 2025
Comprehensive Assessment of Prognostic Factors for Immune-Related Adverse Events in Immune Checkpoint Inhibitor-Treated MelanomaJulian Kött, Myriam Merkle, Lina Bergmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 15, 2024
Differential predictive value of tissue-specific PD-L1 expression scores in adjuvant immunotherapy of melanomaGlenn Geidel, Niousha Parnian, Christian Meß, et al.
Cancers|November 26, 2022
Activated Eosinophils Predict Longer Progression-Free Survival under Immune Checkpoint Inhibition in MelanomaNadine L Ammann, Yasmin F Schwietzer, Christian Mess, et al.
Cancers|July 12, 2025
Serum Complement Factor H: A Marker for Progression and Outcome Prediction Towards Immunotherapy in Cutaneous Squamous Cell CarcinomaGlenn Geidel, Laura Adam, Sabrina Bänsch, et al.
Cancers|May 11, 2024
High Serum Levels of CCL20 Are Associated with Recurrence and Unfavorable Overall Survival in Advanced Melanoma Patients Receiving ImmunotherapyJulian Kött, Inka Lilott Hoehne, Isabel Heidrich, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2024
Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsyJulian Kött, Noah Zimmermann, Tim Zell, et al.
International Journal of Cancer|April 27, 2026
The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint InhibitionTim Zell, Julian Kött, Noah Zimmermann, et al.
Translational Oncology|December 19, 2024
Evaluation of S100A8/A9 and neutrophils as prognostic markers in metastatic melanoma patients under immune-checkpoint inhibitionYasmin F Melzer, Nadine L Fergen, Christian Mess, et al.
Pageof 3